% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • bioimmunomabman bioimmunomabman Oct 26, 2012 9:40 AM Flag


    All the bad news seems to be out now, shorts might start covering here. If T-DM1 gets priority review the stock will move up, the negative royalty news is out, significant revs will be coming in to IMGN starting next year. Even considering I don't have trust/faith in Junius, this might be a good time to buy for a trade IMO. It is possible the price target for IMGN will be reduced by a few of the more bullish analysts, so maybe a low bid will catch a good price drop. $13 is being tested now, let's see if IMGN has any buyers.

1.92-0.07(-3.52%)Oct 28 4:00 PMEDT